Skip to main content
Yanjiu Conference logo

Call for Papers – ICMOCT 2027, Singapore

International Conference on Molecular Oncology and Cancer Therapeutics — ICMOCT 2027

Dates

18–19 January 2027

Venue

Singapore, Singapore

Field

Molecular Oncology and Cancer Therapeutics

Topics of ICMOCT 2027

Original papers are invited in Molecular Oncology and Cancer Therapeutics. Submit by 17 December 2026.

Submit Your Paper

Topics include, but are not limited to:

Molecular Mechanisms of Cancer

  • Genetic mutations in tumorigenesis
  • Role of signaling pathways in cancer
  • Epigenetic factors influencing tumor behavior

Novel Therapeutic Approaches

  • Targeted therapies for specific cancer types
  • Immunotherapy advancements and challenges
  • Small molecule inhibitors in clinical trials

Biomarkers for Early Detection

  • Identification of novel cancer biomarkers
  • Liquid biopsy technologies and applications
  • Machine learning in biomarker discovery

Patient-Centric Treatment Strategies

  • Precision medicine in oncology
  • Development of personalized treatment plans
  • Patient-reported outcomes in cancer care

Translational Research and Drug Development

  • Bench-to-bedside approaches in oncology
  • Pharmaceutical industry collaborations
  • Regulatory challenges in new therapies

Ethical and Societal Implications

  • Ethics of genetic testing and privacy
  • Access to cancer therapies across populations
  • Public perception of oncology research

Important Dates

Conference opens in

00days
00hours
00min
00sec
  1. Step 1

    Submission Deadline

  2. Step 2

    Registration Deadline

  3. Step 3

    Conference Date

Download

Get the official templates and forms for ICMOCT 2027. Use the latest versions when preparing your submission.

Peer Review Process

Follow each step from abstract submission to awards and recognition.

Yanjiuconference peer review process: 12 steps from abstract submission to awards and recognition

See You in Singapore This January

Present your research, meet peers from over 50 countries and help shape the future of Molecular Oncology and Cancer Therapeutics.